Phase I study of T cells redirected to EGFRvIII with a chimeric antigen receptor in patients with EGFRvIII plus glioblastoma

被引：0
|
作者：
O'Rourke, Donald M.
Nasrallah, MacLean P.
Morrissette, Jennifer
Melenhorst, Jan J.
Lacey, Simon F.
Mansfield, Keith
Martinez-Lage, Maria
Desai, Arati
Brem, Steven
Maloney, Eileen
Mohan, Suyash
Wang, Sumei
Verma, Gaurav
Navenot, Jean-Marc
Shen, Angela
Zheng, Zhaohui
Levine, Bruce L.
Okada, Hideho
June, Carl H.
Maus, Marcela V.
机构：
来源：
CANCER RESEARCH | 2016年 / 76卷
关键词：
D O I：
10.1158/1538-7445.AM2016-LB-083
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
LB-083
引用
收藏
页数：3
相关论文
共 50 条
  • [21] Development of third generation anti-EGFRvIII chimeric T cells and EGFRvIII-\-expressing artificial antigen presenting cells for adoptive cell therapy for glioma
    Sahin, Ayguen
    Sanchez, Carlos
    Bullain, Szofia
    Waterman, Peter
    Weissleder, Ralph
    Carter, Bob S.
    PLOS ONE, 2018, 13 (07):
  • [22] Genetically engineered T cells to target EGFRvIII expressing glioblastoma
    Szofia S. Bullain
    Ayguen Sahin
    Oszkar Szentirmai
    Carlos Sanchez
    Ning Lin
    Elizabeth Baratta
    Peter Waterman
    Ralph Weissleder
    Richard C. Mulligan
    Bob S. Carter
    Journal of Neuro-Oncology, 2009, 94 : 373 - 382
  • [23] Smart CARS: optimized development of a chimeric antigen receptor (CAR) T cell targeting epidermal growth factor receptor variant III (EGFRvIII) for glioblastoma
    Ruella, Marco
    Levine, Bruce L.
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (01)
  • [24] Genetically engineered T cells to target EGFRvIII expressing glioblastoma
    Bullain, Szofia S.
    Sahin, Ayguen
    Szentirmai, Oszkar
    Sanchez, Carlos
    Lin, Ning
    Baratta, Elizabeth
    Waterman, Peter
    Weissleder, Ralph
    Mulligan, Richard C.
    Carter, Bob S.
    JOURNAL OF NEURO-ONCOLOGY, 2009, 94 (03) : 373 - 382
  • [25] Chimeric antigen receptor-redirected T cells return to the bench
    Geldres, Claudia
    Savoldo, Barbara
    Dotti, Gianpietro
    SEMINARS IN IMMUNOLOGY, 2016, 28 (01) : 3 - 9
  • [26] B7-H3-redirected chimeric antigen receptor T cells target glioblastoma and neurospheres
    Nehama, Dean
    Di Ianni, Natalia
    Musio, Silvia
    Du, Hongwei
    Patane, Monica
    Polloc, Bianca
    Finocchiaro, Gaetano
    Park, James J. H.
    Dunn, Denise E.
    Edwards, Drake S.
    Damrauer, Jeffrey S.
    Hudson, Hannah
    Floyd, Scott R.
    Ferrone, Soldano
    Savoldo, Barbara
    Pellegatta, Serena
    Dotti, Gianpietro
    EBIOMEDICINE, 2019, 47 : 33 - 43
  • [27] Novel high-affinity EGFRvIII-specific chimeric antigen receptor T cells effectively eliminate human glioblastoma (vol 10, e1283, 2021)
    Abbott, Rebecca C.
    Verdon, Daniel J.
    Gracey, Fiona M.
    Hughes-Parry, Hannah E.
    Iliopoulos, Melinda
    Watson, Katherine A.
    Mulazzani, Matthias
    Luong, Kylie
    D'Arcy, Colleen
    Sullivan, Lucy C.
    Kiefel, Ben R.
    Cross, Ryan S.
    Jenkins, Misty R.
    CLINICAL & TRANSLATIONAL IMMUNOLOGY, 2021, 10 (07)
  • [28] Commentary: Chimeric Antigen Receptor T-Cell Therapy: Updates in Glioblastoma Treatment GLIOBLASTOMA: A CASE FOR CHIMERIC ANTIGEN RECEPTOR T CELLS
    Yu, Xiaoling
    Curry, William T.
    Gerstner, Elizabeth R.
    Cahill, Daniel P.
    Nahed, Brian V.
    Maus, Marcela V.
    Carter, Bob S.
    Choi, Bryan D.
    NEUROSURGERY, 2021, 89 (01) : E68 - E69
  • [29] Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients
    Heimberger, AB
    Hlatky, R
    Suki, D
    Yang, D
    Weinberg, J
    Gilbert, M
    Sawaya, R
    Aldape, K
    CLINICAL CANCER RESEARCH, 2005, 11 (04) : 1462 - 1466
  • [30] Chimeric antigen receptor containing ICOS signaling domain mediates specific and efficient antitumor effect of T cells against EGFRvIII expressing glioma
    Chan-Juan Shen
    Yu-Xiu Yang
    Ethan Q Han
    Na Cao
    Yun-Fei Wang
    Yi Wang
    Ying-Ying Zhao
    Li-Ming Zhao
    Jian Cui
    Puja Gupta
    Albert J Wong
    Shuang-Yin Han
    Journal of Hematology & Oncology, 6
12345